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Abstract 
Background: A pneumococcal conjugate vaccine (PCV) has been part of the Danish childhood immunization 
programme since October 2007. It is administered at the ages of 3, 5 and 12 months and healthy infants younger than 
90 days are consequently not vaccinated. Initially the PCV‑7 vaccine was used but this was replaced by the PCV‑13 in 
April 2010. Vaccination coverage in Denmark is approximately 90 %.The aim of this study was to present multilocus 
sequence typing (MLST) profiles of Streptococcus pneumoniae isolates from Danish infants (0–90 days) with invasive 
pneumococcal disease (IPD) in the period 2003–2013.
Findings: 32 IPD isolates were investigated for their MLST profiles. The identified sequence types (STs) had previously 
been observed in other European countries. Among the clones were ST 306 (serotype 1), ST 180 (serotype 3) and ST 
191 (serotype 7F).
Conclusions: The ST profile distribution in this study is similar to that observed in other European studies and show a 
variety of STs. Our data show that the majority of STs found in Denmark is also observed in other European countries, 
indicating that the IPD isolates were from clones generally circulating in Europe.
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Findings
Invasive pneumococcal disease (IPD) is one of the most 
frequent types of bacteraemia and meningitis in infants 
in Denmark as well as globally [1, 2]. With the introduc-
tion and use of the pneumococcal conjugate vaccines 
(PCV) in children, an effective protection has been pro-
vided against IPD caused by the serotypes included in the 
vaccines [3, 4]. The PCV-7 vaccine was introduced into 
the Danish childhood immunisation programme in Octo-
ber 2007, and in April 2010, it was replaced by a PCV-13 
vaccine [5, 6]. Several studies have shown the effect of 
PCVs on the reduction of vaccine serotypes causing IPD 
[2, 5, 7].
The vaccination of children in Denmark starts at the age 
of 3  months; thus infants younger than 90  days are not 
vaccinated [8]. In a previous study [8], the serotype dis-
tribution for IPD cases from Danish infants (0–90 days) 
during the years 1943–2013 was described. Isolates from 
this study for the period 2003–2013 were tested for their 
clonal relationship using multi locus sequence typing 
(MLST). The present study aims at presenting a descrip-
tive investigation on (1) whether the IPD isolates found 
in this group of children are dominated by a few clonal 
complexes or a variety of isolates consisting of singletons, 
and (2) if these IPD isolates belong to clones that circu-
late in Denmark only or are generally found in Europe.
Eligible for inclusion in the study were 44 IPD cases 
from the period 2003 to 2013. Detailed background 
information, e.g. inclusion criteria and pneumococcal 
identification details including phenotypic serotyping has 
previously been published [8]. Of the 44 cases, viable bio-
logical material was non-existent for 12 of them, all from 
before 2007. Thus, only 32 isolates could be analysed for 
their MLST profiles. The study is based on isolates from 
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the national laboratory surveillance data on IPD. Since 
data and samples from patients were collected routinely 
for diagnostic and national surveillance purposes, no 
ethical approval or informed consents from parents or 
guardians were required. The study was approved by 
the Danish Data Protection Agency (record number 
2007-41-0229).
The MLST analysis was performed at the Neisseria 
and Streptococcus Reference (NSR) laboratory at Stat-
ens Serum Institut (SSI) using a protocol previously 
described [9]. Briefly, the MLST primer pairs for aroE, 
gdh, gki, recP, spi, xpt, and ddl were used as described 
in the MLST online database (http://pubmlst.org/). All 
sequences were analysed using the BioNumerics software 
(Applied Maths, Sint-Martens-Latem, Belgium). Analysis 
and annotation of sequences for MLST were performed 
by the online tool at http://pubmlst.org/. From the allelic 
distance, groups of closely related isolates were identified. 
In this study, a clonal complex was defined as isolates 
sharing six of the seven loci that define the allelic profile, 
as defined by Feil et al. [10] and as used in recent studies 
[11, 12]. Clonal relationships based on the sharing of five 
out of the seven loci was also investigated. BioNumerics 
and eBURSTV3 software (http://pubmlst.org/) were used 
to establish the relationship among the isolates.
Table  1 presents the serotypes and MLST profiles of 
the 32 viable isolates. A variety of sequence types (STs) 
were found, and for some serotypes the same ST was 
observed over several years. eBURST analysis based on 
similarities in 6 out of 7 loci revealed that the STs were 
dominated by 16 singletons and 3 groups of related STs 
and that there were no predicted founder. Five of the 
nine serotype 7F isolates were ST 191, one was ST 1589 
(which is related to ST 191, only one of the seven loci 
is different), and three were ST 1176. The two analysed 
serotype 1 isolates belonged to the same ST 306, one 
from 2004 and the other from 2011. A similar observa-
tion was also observed with two serotype 3 isolates which 
both were ST 180. Regarding non-vaccine types, the two 
serotype 6C isolates from 2008 and 2009 were ST 481 
and ST 1692, respectively. Serotype 8 from 2003 was ST 
53, and the serotype 8 isolate (ST 9761) from 2013 was 
clonally related to ST 53. The performance of a new 
eBURST analysis based on five out of the seven loci did 
not change the observations made when using six out of 
seven loci. The ST 177, ST 2731, ST 9761, ST 53, ST 191 
and ST 1589 were found to be SLV, while all other STs in 
this study were singletons. No DLV or TLV were found.
In the study by Lambertsen et  al. [9] invasive penicil-
lin non-susceptible S. pneumoniae from Denmark in 
the period from 2001 to 2005 were described. The study 
presented the MLST profiles of 43 isolates, showing that 
there were dominating clonal complexes, but also that 
the isolates showed many singletons. To the authors’ 
knowledge, this is the only other study describing the 
MLST distribution of invasive pneumococcal isolates 
in Denmark. It has to be considered that Lambertsen 
et  al. [9] presented selected data (only penicillin non-
susceptible isolates from before the PCV introduction 
in Denmark) while the present study presents data on 
isolates obtained after the PCV introduction and moreo-
ver only from infants. Hence, the two studies cannot be 
compared. The MLST profiles from the two studies are 
also very different, and only a few STs were either iden-
tical or clonally related between both studies, while the 
majority were different STs. 37 of the 43 tested isolates in 
the study by Lambertsen et al. [9] belonged to serotypes 
included in the PCV-7 and two belonged to the PCV-13 
serotypes. Today, the circulation of serotypes included 
in the PCV-7 has been extensively reduced due to the 
impact of the vaccine. Moreover, since penicillin non-
susceptibility is often associated with certain serotypes, 
the current study and the Lambertsen study would be 
expected to be very different with respect to serotypes as 
well as STs. The effect of the PCV-7 introduction in 2007 
in Denmark [5] might be the reason why the PCV-7 sero-
types found in the Lambertsen et  al. study [9] are very 
seldomly observed today in Denmark [5].
The MLST profiles found in this study belong to well-
known STs also found in other European countries 
[13–15]. Among these are ST 306 (serotype 1), ST 180 
(serotype 3) and ST 191 (serotype 7F) (Table  1). Sev-
eral of the STs reappeared over the years such as ST 306 
(serotype 1) in 2004, 2011, and 2013, and ST 180 (sero-
type 3) in 2004 and 2011 (Table 1). This occurrence of STs 
over several years has also been described by Ardanuy 
et  al. [13], who found ST 306 (serotype 1) and ST 180 
(serotype 3) in 1999–2000 and again in 2007–2009. The 
observation that the STs in this study are generally seen 
in other European countries [13–15] may indicate that 
the majority of IPD isolates observed in unvaccinated 
Danish infants belong to strains that circulate generally 
in Europe and not only in Denmark. Two of the three 
non-vaccine serotypes [ST 9761 (serotype 8) and ST 
989 (serotype 12F)] observed in 2011, 2012 and 2013 are 
clonally related (using the 6/7 loci definition) to serotypes 
in other European countries according to the Strepto-
coccus pneumoniae isolates MLST database (Accessed 
12 March 2015, http://pubmlst.org/). Apparently, the 
ST 9760 (serotype 27) strain observed in 2011 has only 
been found in Denmark previously, and is not clonally 
related to other serotypes using the 6/7 loci definition. To 
the authors’ knowledge, this ST has not been described 
elsewhere or recorded in other countries according to the 
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MLST database (Accessed 20 July 2015, http://pubmlst.
org/). Serotype 27 is rarely observed in Denmark, and 
since 2003 there has only been confirmed five IPD cases 
due to serotype 27.
In conclusion, the MLST profiles of IPD isolates from 
Danish unvaccinated infants younger than 90 days in this 
study are similar to the profiles observed in Europe. The 
isolates show a variety of STs that exceeds the number of 
different serotypes. There are, however, STs that reappear 
over the years from 2003 to 2013. The serotypes appearing 
after the PCV introduction are in general clones observed 
in other European countries, suggesting that future sero-
types appearing in Denmark may well be clones already 
circulating in Europe, although domestic pneumococcal 
clones such as ST 9760 (serotype 27) also appear.
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Table 1 Pneumococcal serotypes and MLST profiles from Danish infants younger than 90 days with invasive pneumococ-
cal disease from 2003 through 2013
a 12 isolates from before 2007 were not available, so no STs could be established for these isolates
Year Number  
of isolates
PCV-7 serotypes  
(MLST-profiles in parentheses)
















2006 4 6Ba 1a
3a
7F (ST 1176)
October 2007: introduction of PCV-7 in the Danish childhood immunisation programme











2009 3 18C (ST 113) 7F (ST 1589) 6C (ST 1692)
April 2010: introduction of PCV-13 in the Danish childhood immunisation programme
2010 3 3 (ST 9107)
7F (ST 191)
19A (ST 199)




2012 1 12F (ST 989)
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